Adamax 10mg

$44.99

  • Compound: Adamax
  • Amount: 10mg
  • Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly
  • Molecular Formula: C50H69N11O11S
  • Molecular Weight: 1032.23 g/mol
  • CAS Number: N/A
  • Vial Size: 3mL
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPADX10 Categories: , Tags: , ,
Description

Adamax 10mg – Powerful Peptide Research Material

Adamax 10mg is a peptide research material supplied in a 3mL vial with the sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly. Its supplied molecular formula is C50H69N11O11S, with a molecular weight of 1032.23 g/mol.

The available specifications provide useful reference points for material identification, laboratory documentation, and comparison with relevant scientific records. No PubChem CID was supplied, and the CAS number is listed as N/A, so neither identifier is being inferred.

Adamax 10mg Research Overview

The supplied product specifications are:

Specification Product Information
Compound Adamax
Amount 10mg
Sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly
Molecular Formula C50H69N11O11S
Molecular Weight 1032.23 g/mol
CAS Number N/A
Vial Size 3mL

The 10mg quantity describes the amount of research material supplied, while 3mL describes vial capacity. Neither specification independently establishes an experimental concentration or administration quantity.

Sequence and Molecular Specifications

The supplied sequence is:

Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly

The molecular formula is:

C50H69N11O11S

The supplied molecular weight is 1032.23 g/mol.

Together, these characteristics provide researchers with several reference points for documenting and comparing the material.

The supplied technical information lists the CAS number as N/A, and no PubChem CID was provided. This page therefore does not assign unverified chemical identifiers.

Peptide Research Identification

The supplied sequence and molecular characteristics should remain central when identifying this research material.

Relevant specifications include:

  • Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly sequence
  • C50H69N11O11S molecular formula
  • 1032.23 g/mol molecular weight
  • 10mg material quantity
  • 3mL vial capacity

Researchers can document these characteristics alongside experiment-specific parameters to maintain clear records and facilitate comparison between studies.

Peptide Research Context

The phrase adamax peptides may appear in online searches concerning this material.

For laboratory purposes, keyword terminology should not replace molecular identification. Researchers should compare sequence, molecular formula, molecular weight, material quantity, and product format when determining whether scientific information relates to the same research material.

Controlled investigation may additionally document the research model, concentration, controls, sample preparation, analytical methodology, observation conditions, and measured endpoints.

Informational Search Context

Users searching what is adamax peptide are generally seeking basic information about the material.

Based strictly on the supplied specifications, the product is a peptide research material with the sequence Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly, molecular formula C50H69N11O11S, and molecular weight 1032.23 g/mol.

No mechanism, therapeutic indication, clinical outcome, or human-use application was supplied. Such claims are therefore not inferred from the product name or molecular specifications.

Research Quantity and Experimental Design

Searches involving adamax peptide dosage should be distinguished from laboratory material specifications.

This product contains 10mg total research material. That quantity describes the amount supplied in the vial and is not a human dose, treatment quantity, injection amount, frequency, or administration recommendation.

Controlled research may instead establish experiment-specific variables such as:

  • Research model
  • Experimental concentration
  • Sample volume
  • Material preparation
  • Appropriate controls
  • Exposure conditions
  • Analytical methodology
  • Observation period
  • Experimental endpoints
  • Reproducibility

Experimental parameters should correspond to the specific research methodology being used.

Safety Research and Evidence

Searches for adamax peptide side effects reflect safety-related informational intent.

The supplied product information does not include clinical safety studies, toxicology results, adverse-event data, or human-use information sufficient to establish specific side effects.

Researchers investigating safety questions should distinguish among controlled experimental evidence, peer-reviewed scientific literature, database information, and anecdotal reports.

A lack of supplied safety information should never be interpreted as evidence that a research material is safe for human use.

10mg Research Format

This product contains 10mg of specified peptide research material in a 3mL vial.

These values describe product quantity and physical container capacity. They do not independently establish final preparation volume, experimental concentration, or administration parameters.

No solvent, reconstitution procedure, storage requirement, preparation concentration, or stability information was supplied. Those characteristics are therefore not being inferred.

Laboratory Documentation

Researchers may document the supplied product characteristics as:

Compound: Adamax
Amount: 10mg
Sequence: Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly
Molecular Formula: C50H69N11O11S
Molecular Weight: 1032.23 g/mol
CAS Number: N/A
Vial Capacity: 3mL

Experiment-specific records can separately include research concentration, experimental model, controls, preparation conditions, analytical procedures, observation period, and measured endpoints.

Separating product specifications from experimental parameters helps maintain clear research documentation.

Evaluating Scientific Research

Researchers reviewing information about this material should determine whether the substance described in a source corresponds to the supplied molecular specifications.

Important comparison factors can include:

  • Exact material identity
  • Sequence
  • Molecular formula
  • Molecular weight
  • Product format
  • Research model
  • Experimental concentration
  • Controls
  • Study methodology
  • Analytical procedures
  • Observation conditions
  • Experimental endpoints

Information from commercial descriptions, community discussions, or unrelated compounds should not automatically be treated as equivalent to controlled experimental evidence.

Research Evidence and Material Verification

Research involving materials with limited supplied database information requires careful source evaluation.

Researchers should distinguish between original experimental publications, structured database records, scientific reviews, commercial descriptions, and informal community reports.

For this product, no PubChem CID was supplied. A compound-specific PubChem identifier is therefore not asserted here.

Any database record considered relevant should be compared against the supplied sequence, molecular formula, molecular weight, and other available identifiers before being attributed to this material.

Related OROS Research Materials

Researchers can review OR-2T 5mg as a separately specified research material.

Additional strengths include OR-2T 10mg and OR-2T 20mg.

The catalog also includes Pinealon 20mg as an independently specified peptide research material.

Each product has its own supplied specifications and should be identified and documented separately.

Scientific Research Resources

Researchers can use PubChem when investigating available molecular and chemical database records.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

Database records should be compared carefully with sequence, molecular formula, molecular weight, and other available identifying characteristics before being attributed to a specific material.

Frequently Asked Questions

What is Adamax peptide?

Adamax is the peptide research material described on this page. The supplied product contains 10mg of material in a 3mL vial.

What is the supplied sequence?

The sequence is Ac-Met-Glu-His-Phe-Pro-Gly-Pro-Ala-Gly.

What is the molecular formula?

The supplied molecular formula is C50H69N11O11S.

What is the molecular weight?

The supplied molecular weight is 1032.23 g/mol.

Is a CAS number supplied?

No. The supplied product specifications list the CAS number as N/A, so an alternative identifier has not been inferred.

How much research material is supplied?

The vial contains 10mg of specified material. This is a product quantity rather than human dosing or administration guidance.

Are human side effects established by these specifications?

No. The supplied specifications do not provide clinical safety or adverse-event evidence from which human side effects could be established.

What size vial is supplied?

The material is supplied in a 3mL vial. Container capacity does not independently determine preparation volume or experimental concentration.

Research Use Disclaimer

This research material is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Material quantity and vial capacity are product specifications and do not constitute human dosing or administration guidance. No clinical safety or therapeutic claims are made. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, athletic performance enhancement, bodybuilding, or veterinary application.

Additional information
Net Weight

10mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Adamax 10mg”

Your email address will not be published. Required fields are marked *